Manufacturing and Production

Showing 15 posts of 5863 posts found.

cruk_logo

Cancer Research UK announces push for earlier cancer detection

October 22, 2019 Manufacturing and Production

Cancer Research UK has embarked on a new international alliance with a plan to develop ‘radical new strategies’ and technologies …
vertex-headquarters

US FDA approves Vertex’s new breakthrough therapy for cystic fibrosis

October 22, 2019 Manufacturing and Production

The US FDA has approved Trikafta (elexacaftor/ivacaftor/tezacaftor) – the first triple combination therapy available for patients with most common cystic …
brexit-hintergrund_web

“No deal” Brexit and life sciences: What happens?

October 21, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Europe, UK, brexit, no deal, no-deal, pharma

Prime Minister Boris Johnson may have agreed a withdrawal agreement with the European Union at the 11th hour, but despite …

Medical cannabis: Growth by leaps and bounds

October 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Canopy Growth, medical cannabis, pharma

This article follows parts one and two of our trio of in-depth pieces focusing on the growing medical cannabis phenomenon. …
top_10_photo

Top Ten most popular articles on Pharmafile.com this week

October 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s time for a rundown of the top 10 articles on PharmaFile this past week. The past seven days saw …
andrew_dickinson

Gilead appoints Andrew Dickinson as CFO

October 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead Sciences have announced that Andrew Dickinson has been appointed as Chief Financial Officer (CFO) effective 1 November. Dickinson currently …
_dsc6281_1

Medical cannabis: Riding the wave

October 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kanabo research, medical cannabis, pharma

Following on from our previous piece from Mewburn Ellis on the history of social attitudes towards cannabis, Israel-based Kanabo Research …
london-2393098_960_720

New UK Medicines Bill could improve access to new dementia treatments

October 15, 2019 Manufacturing and Production

The Government has announced new legislation aimed at providing faster access to medicines, including those treating dementia and Alzheimer’s.The Medicines …

Lilly’s Reyvow becomes first FDA-approved 5-HT1F receptor agonist for acute migraine

October 15, 2019 Manufacturing and Production, Sales and Marketing Eli Lilly, FDA, Reyvow, US, migraine, pharma

Eli Lilly has announced that the FDA has given the green light to Reyvow (lasmiditan) in the acute treatment of …
180802_parkinsons_uk

New £1.2m trial for Parkinson’s patients testing cannabidiol

October 15, 2019 Manufacturing and Production

A new clinical trial at King’s College London will investigate the use of cannabidiol (CBD) – a compound found in …
janssen_latest_logo_on_sign_closer

FDA approves Janssen’s Xarelto for blood clot prevention

October 15, 2019 Manufacturing and Production, Sales and Marketing FDA, Janssen, US, Xarelto, pharma, thromboembolism

Janssen’s Xarelto (rivaroxaban) has secured FDA approval for the prevention of venous thromboembolism (VTE), or blood clots, in hospitalised acutely …
17806842-15615029782758005_origin

Reata reports top-line data for omaveloxolone in Freidreich’s ataxia

October 15, 2019 Manufacturing and Production

Reata has reported that Part 2 of its mid-stage MOXIe trial of its Nrf2 activator omaveloxolone met its primary endpoint. …
_dsc6538

Medical cannabis: On to greener pastures?

October 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medical cannabis, medicinal cannabis, pharma

In the first of three articles on the topic, Callum McGuinn, Associate and European Patent Attorney at Mewburn Ellis, explores …

Three focus areas to accelerate breakthrough drugs to market

October 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing veeva

The number of clinical trials taking place each year continues to rise. In fact, in 2018, the FDA approved a …
jim_greenwood

Biotechnology Innovation Organization Chief to step down after US 2020 elections

October 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotechnology Innovation Organization, US, biotech, pharma

The Biotechnology Innovation Organization (BIO), the largest trade body representing the world’s biotechnology industry, has revealed that its President and …
The Gateway to Local Adoption Series

Latest content